Gill Capital Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-145
Closed -$35.9K – 304
2026
Q2
$35.9K Hold
145
– – 0.01% 309
2026
Q1
$29.1K Buy
+145
New +$30K 0.01% 321

Other funds holding FBT

Gill Capital Partners's FBT Position: Q3 2026 in Review

Gill Capital Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026, closing a stake of 145 shares — an estimated $35.9K sold.

Gill Capital Partners first reported a position in FBT in Q1 2026 and held it in 2 quarters. The position peaked at $35.9K in Q2 2026. 315 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Gill Capital Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2026 after selling out during the quarter.
  • Gill Capital Partners sold 145 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $35.9K.
  • Gill Capital Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and held it in 2 quarters.
  • Gill Capital Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $35.9K in Q2 2026.
  • 315 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Gill Capital Partners's 13F filing for Q3 2026, filed 13 Oct 2026.